Ivabradine 7.5 mg

What is Ivabradine 7.5 mg?

Ivabradine 7.5 mg is a prescription medication primarily used for the management of certain heart conditions. It contains the active ingredient Ivabradine, which plays a critical role in controlling heart rate by selectively inhibiting the pacemaker activity in the heart. This targeted mechanism makes Ivabradine 7.5 mg an important option for patients dealing with chest pain due to angina as well as heart failure.

Manufactured by Lupin Limited, Ivabradine 7.5 mg is used extensively in Canada and other countries as part of comprehensive cardiovascular care. The drug is especially valuable for patients who require heart rate reduction but are unable to tolerate other standard treatments.

Uses of Ivabradine 7.5 mg

• Treatment of stable angina (chest pain) in adults
• Management of chronic heart failure with reduced ejection fraction
• Reduction of symptoms related to ischemic heart disease
• Complementary therapy when beta-blockers are contraindicated or not sufficient

How Ivabradine 7.5 mg Works

Ivabradine acts by selectively inhibiting the "funny" (If) current in the sinoatrial node, the natural pacemaker of the heart. This inhibition slows the heart rate without affecting myocardial contractility or blood pressure significantly. By reducing the heart rate, Ivabradine 7.5 mg decreases myocardial oxygen demand, which helps alleviate angina symptoms and improves cardiac efficiency in heart failure patients.

Benefits of Ivabradine 7.5 mg

• Effective heart rate reduction leading to symptom relief
• Improves exercise tolerance in angina patients
• Supports management of chronic heart failure symptoms
• Does not reduce blood pressure significantly, suitable for specific patient groups
• Offers an alternative for patients intolerant to beta-blockers

Dosage and Administration

Ivabradine 7.5 mg is typically taken orally twice daily, with or without food. The exact dose and duration of therapy should be determined by a healthcare professional based on the patient's condition and response. It is important to follow prescribed instructions and not to exceed the recommended dose. Regular monitoring of heart rate and overall cardiac function is advised during treatment.

Who Should Use Ivabradine 7.5 mg?

This medication is suitable for adults who suffer from chronic stable angina or heart failure and require effective heart rate control. It is especially beneficial for those who have contraindications to beta-blockers or require additional heart rate reduction. Patients under careful medical supervision can benefit from the targeted action of Ivabradine 7.5 mg.

Who Should Avoid Ivabradine 7.5 mg?

Ivabradine 7.5 mg should be avoided by patients with:

• Severe bradycardia (slow heart rate below 60 bpm)
• Hypotension (low blood pressure)
• Acute heart failure or unstable angina
• Severe liver impairment
• Known hypersensitivity to Ivabradine or any drug components
• Patients with pacemaker dependency or arrhythmias such as sick sinus syndrome

Side Effects

• Visual disturbances, such as luminous phenomena or phosphenes
• Bradycardia (abnormally slow heartbeat)
• Headache
• Dizziness
• Blurred vision
• Fatigue
• Constipation

Safety Advice

• Do not exceed the prescribed dose to avoid severe bradycardia
• Inform your doctor if you experience visual symptoms or unusual fatigue
• Avoid driving or operating machinery if dizziness or visual disturbances occur
• Regularly monitor heart rate and blood pressure during treatment
• Consult physician before stopping treatment abruptly
• Discuss all medications with your healthcare provider to avoid interactions

Drug Interactions

• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) increase Ivabradine levels and risk of side effects
• Other heart rate lowering drugs may enhance bradycardia risk
• Calcium channel blockers like verapamil and diltiazem can increase drug concentration
• Use with caution alongside beta-blockers

Storage Instructions

Store Ivabradine 7.5 mg tablets in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children. Do not use the medication past the expiration date. Proper storage helps maintain medicine effectiveness and safety.

Where to buy Ivabradine 7.5 mg in Canada?

Ivabradine 7.5 mg is available through licensed Canadian pharmacies and healthcare providers. Purchase from reputable sources to ensure product authenticity and quality. Some online Canadian pharmacies offer secure purchasing options, but a prescription from a healthcare professional is required for sale.

Frequently Asked Questions (FAQ)

Is Ivabradine 7.5 mg available in Canada?

Yes, Ivabradine 7.5 mg is available in Canada through prescription and can be purchased at pharmacies with a valid prescription from a licensed physician.

What is the price of Ivabradine 7.5 mg in Canada?

The price of Ivabradine 7.5 mg varies depending on the pharmacy and insurance coverage. It is advisable to consult local pharmacies or healthcare providers for current pricing information.

What happens if I miss a dose?

If you miss a dose of Ivabradine 7.5 mg, take it as soon as you remember unless it is close to the time of your next dose. Do not double the dose to catch up. Always follow your doctor’s guidance regarding missed doses.

Where can I find Ivabradine 7.5 mg for sale?

Ivabradine 7.5 mg can be purchased at licensed pharmacies in Canada with a valid prescription. It is important to buy from trusted sources to ensure safety and authenticity.

Can Ivabradine 7.5 mg be taken with other heart medications?

Ivabradine can interact with some heart medications. Always inform your healthcare provider about all medicines you are taking to avoid harmful interactions.

Are there any special precautions while using Ivabradine 7.5 mg?

Yes, patients should have regular heart monitoring and report any unusual symptoms such as vision changes or excessive fatigue to their healthcare provider immediately.

How long does it take for Ivabradine 7.5 mg to work?

Ivabradine begins to lower heart rate within hours of the first dose, but noticeable symptom improvement may take several weeks. Follow your doctor's instructions and attend scheduled check-ups.

Conclusion

Ivabradine 7.5 mg by Lupin Limited offers a targeted, effective solution for patients in Canada managing chest pain caused by angina and chronic heart failure. With its unique mechanism to reduce heart rate without significantly affecting blood pressure, it provides a valuable treatment option. Proper usage, monitoring, and adherence to safety advice ensure maximum benefits and minimize risks. Always consult a healthcare professional before starting or adjusting therapy with Ivabradine 7.5 mg.